{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:49:12Z","timestamp":1788184152661,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.atherosclerosis.2011.05.039","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T09:52:31Z","timestamp":1308563551000},"page":"285-290","source":"Crossref","is-referenced-by-count":14,"title":["Increased lipoprotein(a) is associated with polyvascular disease in patients undergoing coronary artery bypass graft"],"prefix":"10.1016","volume":"219","author":[{"given":"Pamela","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Myoung","family":"Seok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wook Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Tak","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyeong-Moon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0005","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jama.294.10.1255","article-title":"Trends in the leading causes of death in the United States, 1970\u20132002","volume":"294","author":"Jemal","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0015","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/eurheartj\/ehp099","article-title":"Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes","volume":"30","author":"Bhatt","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0020","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/1358863X10373299","article-title":"Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry","volume":"15","author":"Suarez","year":"2010","journal-title":"Vasc Med"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0030","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1093\/eurheartj\/ehp355","article-title":"Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry","volume":"30","author":"Alberts","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0035","doi-asserted-by":"crossref","first-page":"57U","DOI":"10.1016\/S0002-9149(98)00954-0","article-title":"Lipoprotein(a) as a risk factor for coronary artery disease","volume":"82","author":"Marcovina","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00041433-199906000-00005","article-title":"Lipoprotein(a): intrigues and insights","volume":"10","author":"Hobbs","year":"1999","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0045","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.cll.2006.07.002","article-title":"Lipoprotein(a): a unique risk factor for cardiovascular disease","volume":"26","author":"Anuurad","year":"2006","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids. Lp(a) lipoprotein, and coronary artery disease","volume":"353","author":"Tsimikas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0055","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.atherosclerosis.2010.07.007","article-title":"Elevated serum lipoprotein(a) as a potential predictor for combined intracranial and extracranial artery stenosis in patients with ischemic stroke","volume":"212","author":"Kim","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0060","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.STR.0000222666.21482.b6","article-title":"Lipoprotein(a) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study","volume":"37","author":"Ohira","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0065","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0070","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000081812","article-title":"Mannheim intima-media thickness consensus","volume":"18","author":"Touboul","year":"2004","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00013644-200312000-00005","article-title":"Carotid artery stenosis: grayscale and Doppler ultrasound diagnosis \u2013 Society of Radiologists in Ultrasound consensus conference","volume":"19","author":"Grant","year":"2003","journal-title":"Ultrasound Q"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0080","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0085","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/01.ATV.18.4.641","article-title":"Increased degradation of lipoprotein(a) in atherosclerotic compared with nonlesioned aortic intima-inner media of rabbits: in vivo evidence that lipoprotein(a) may contribute to foam cell formation","volume":"18","author":"Nielsen","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.clinbiochem.2003.12.007","article-title":"Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models","volume":"37","author":"Boffa","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0095","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1161\/ATVBAHA.108.169292","article-title":"Lipoprotein(a) is associated differentially with carotid stenosis, occlusion, and total plaque area","volume":"28","author":"Klein","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0100","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archinte.168.6.598","article-title":"Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data","volume":"168","author":"Bennet","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0105","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1161\/STROKEAHA.106.480657","article-title":"Lipoprotein (a) and stroke: a meta-analysis of observational studies","volume":"38","author":"Smolders","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0110","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","article-title":"Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies","volume":"102","author":"Danesh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0115","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0120","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0735-1097(02)02769-9","article-title":"Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes","volume":"41","author":"Tsimikas","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1172\/JCI115855","article-title":"Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations","volume":"90","author":"Boerwinkle","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.ATV.5.3.265","article-title":"Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B","volume":"5","author":"Guyton","year":"1985","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0135","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/BF00201550","article-title":"Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups","volume":"86","author":"Sandholzer","year":"1991","journal-title":"Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0140","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/S0022-2275(20)37461-7","article-title":"Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans","volume":"37","author":"Marcovina","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0145","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa001066","article-title":"Lp(a) lipoprotein, vascular disease, and mortality in the elderly","volume":"349","author":"Ariyo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0150","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.amjmed.2006.07.032","article-title":"Body mass, fitness and survival in veteran patients: another obesity paradox?","volume":"120","author":"McAuley","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0155","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehp162","article-title":"Explaining the obesity paradox: cardiovascular risk, weight change, and mortality during long-term follow-up in men","volume":"30","author":"Strandberg","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2011.05.039_bib0160","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/eurheartj\/ehp317","article-title":"Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention","volume":"31","author":"Hastie","year":"2010","journal-title":"Eur Heart J"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011004746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011004746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T23:30:28Z","timestamp":1637883028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915011004746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0021915011004746"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.05.039","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}